Severe hyperprolactinemia during lurasidone treatment in a 16-year old girl with schizophrenia – a case report
Categoría del artículo: Case Report
Publicado en línea: 03 jul 2022
Páginas: 87 - 88
DOI: https://doi.org/10.2478/sjcapp-2022-0009
Palabras clave
© 2022 Karsten Gjessing Jensen, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Background
Increase of serum prolactin is a common adverse effect to antipsychotic medication, potentially leading to galactorrhea, menstrual cycle disturbances or sexual adverse effects. Lurasidone is commonly associated with a low risk of prolactin change.
Objective
To describe a case of severe hyperprolactinemia in a 16-year old female with schizophrenia.
Method
Case report.
Results
We saw a severe and sustained prolactin increase during treatment with lurasidone.
Conclusions
Although lurasidone is usually considered not to increase prolactin, some patients may experience this adverse effect. As related subjective consequences may be falsely attributed to the disease or as direct effects of the antipsycotic agent, serum prolactin measurements should be made prior to and during antipsychotic treatment regardless of medication choice.